Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Doxofylline and Glucose Injection

Approval Number

国药准字H20031017

Company吉林康乃尔药业有限公司

Registration Date

August 31, 2021

Previous Approval Numbers

国药准字H20031017

Drug Information

Generic Name

多索茶碱葡萄糖注射液

Trade Name

迈平希

Brand Name

迈平希

Dosage Form

注射剂

Strength

100ml:多索茶碱0.3g与葡萄糖5g

Drug Type

化学药品

Registration Date

August 31, 2021

Company Information

Applicant Company

Company Name吉林康乃尔药业有限公司

Company Address

吉林市高新区深圳街95号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy